Copyright ©The Author(s) 2021.
World J Gastroenterol. Jun 14, 2021; 27(22): 3037-3049
Published online Jun 14, 2021. doi: 10.3748/wjg.v27.i22.3037
Figure 3
Figure 3 Response assessment with contrast-enhanced computed tomography after neoadjuvant therapy. A-C: A 58-year-old woman with a 5.6 cm × 4.2 cm tumor in the pancreatic body and tail with non-uniform low-density (A), showing slightly enhancement relative to the surrounding parenchyma in the arterial phase (B), with invasion of the left renal vein as seen in the portal venous phase (C); D-F: After 2.5 mo of neoadjuvant treatment (nab-paclitaxel combined with gemcitabine), the tumor size was reduced to 4.7 cm × 4.2 cm (D), small patchy enhancement was seen in the original lesion (E), and the degree of invasion of the left renal vein was reduced (F).